However, a 4-week treatment with roflumilast was shown to reduce the sputum level of CXCL8 and the sputum neutrophil count in a small group of COPD patients treated with short-acting bronchodilators (Grootendorst et al., 2007). The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.